1 enrolling by invitation. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow SPC 5002: new trials by email Literature Review of SPC 5002 trials Research Report on SPC 5002
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension SPC1001 Low, SPC5002, SPC5003 - Hypertension (HTN), NYHA Class III Heart Failure | Phase 2 | Enrolling by invitation | Shin Poong Pharmaceutical Co. Ltd. | 252 | 2024-12-05 | 2025-07-14 |
Diabetes Mellitus (1) · Hypertension (1)
Shin Poong Pharmaceutical Co. Ltd. (1)
South Korea (1)